We have demonstrated that HMGB1 administration achieved the similar benefits to the BMC-mediated paracrine effects, including decreased fibrosis, increased vascular formation, attenuated cardiomyocyte hypertrophy, and attenuated inflammation in a rat ischemic cardiomyopathy model [17]. The gene discussed is HMGB1; the disease is ischemic cardiomyopathy.